193 related articles for article (PubMed ID: 34560543)
21. Non-coding landscapes of colorectal cancer.
Ragusa M; Barbagallo C; Statello L; Condorelli AG; Battaglia R; Tamburello L; Barbagallo D; Di Pietro C; Purrello M
World J Gastroenterol; 2015 Nov; 21(41):11709-39. PubMed ID: 26556998
[TBL] [Abstract][Full Text] [Related]
22. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
[TBL] [Abstract][Full Text] [Related]
23. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
24. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
Balasubramanian SK; Sharma M; Venur VA; Schmitt P; Kotecha R; Chao ST; Suh JH; Angelov L; Mohammadi AM; Vogelbaum MA; Barnett GH; Jia X; Pennell NA; Ahluwalia MS
Neuro Oncol; 2020 Feb; 22(2):267-277. PubMed ID: 31648302
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a five-gene model to predict postoperative brain metastasis in operable lung adenocarcinoma.
Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Chen H
Int J Cancer; 2020 Jul; 147(2):584-592. PubMed ID: 32181877
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
[TBL] [Abstract][Full Text] [Related]
27. The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database.
Shen H; Deng G; Chen Q; Qian J
BMC Cancer; 2021 Jul; 21(1):825. PubMed ID: 34271858
[TBL] [Abstract][Full Text] [Related]
28. Noncoding RNAs and pancreatic cancer.
Peng JF; Zhuang YY; Huang FT; Zhang SN
World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
[TBL] [Abstract][Full Text] [Related]
29. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA CASC19 facilitates non-small cell lung cancer cell proliferation and metastasis by targeting the miR-301b-3p/LDLR axis.
Wang L; Lin C; Sun N; Wang Q; Ding X; Sun Y
J Gene Med; 2020 Dec; 22(12):e3254. PubMed ID: 32677267
[TBL] [Abstract][Full Text] [Related]
32. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
Yu X; Sheng J; Pan G; Fan Y
Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
35. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
36. Non-coding RNAs in gastric cancer.
Xie S; Chang Y; Jin H; Yang F; Xu Y; Yan X; Lin A; Shu Q; Zhou T
Cancer Lett; 2020 Nov; 493():55-70. PubMed ID: 32712234
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets.
Chen J; Wang R; Zhang K; Chen LB
J Cell Mol Med; 2014 Dec; 18(12):2425-36. PubMed ID: 25297942
[TBL] [Abstract][Full Text] [Related]
38. Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.
Chen Y; Lu L; Feng B; Han S; Cui S; Chu X; Chen L; Wang R
Oncotarget; 2017 May; 8(22):36787-36799. PubMed ID: 28415568
[TBL] [Abstract][Full Text] [Related]
39. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
40. An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis.
Soofiyani SR; Hosseini K; Soleimanian A; Abkhooei L; Hoseini AM; Tarhriz V; Ghasemnejad T
Microrna; 2021; 10(3):181-190. PubMed ID: 34514995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
